Clinical Chemistry

In Other News

• Circulating Tumor Cell Count Predicts Prostate Cancer Outcome Better Than PSA Measurement Does

• Simplified Microchip Electrophoresis Rapidly Separates Urinary Proteins

• New Microarray-Based Glycoprofiling Test Diagnoses Ovarian Cancer

• New Gene Linked to Key Heart Attack Risk Factor

• Novel Candidate Protein Biomarkers Identified for Gastric Cancer

• Elevated Urinary Globotriaosylceramide Suggested as New Heart Disease Biomarker

• New Blood-Test Evaluated to Identify Women at Risk for Ovarian Cancer

• New Supermix Controls to Streamline QC in Clinical Laboratories

• Photometric Tests for Common Electrolytes Provide High-Precision Alternative

• BPA Linked to Prostate Cancer, May Serve as Important Biomarker

• Blood Test Identifies Seniors At-Risk for Cognitive Impairment or Alzheimer's Years in Advance of Onset

• Molecular Biomarkers Tested for Schizophrenia

• Laboratories Validate New Clinical Test for Acute Kidney Injury

• Rise in Blood Levels of Heart Muscle Protein an Early Diagnostic Marker for Cardiac Injury

• Nano-Based Urine Test to Enable Low-Cost Point-of-Care Cancer Diagnosis

• Cortisol Identified as Biomarker for Severe Depression in Teenage Boys

• Prognostic Tool Predicts Pediatric Septic Shock Mortality Risk

• Protein Test Improves Survival Prediction for Oropharyngeal Carcinoma

• Dedicated Blood DNA Collection Tube Receives European Marketing Approval

• Reference Ranges Established for Automated Cerebrospinal Fluid Cell Count

• Exhaled Breath Compounds Identify Early Lung Cancer

• Glycated Hemoglobin Levels Accurately Predict Risk of Type II Diabetes

• Risk Factor Identified for Life-Threatening Disease in Premature Infants